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Thioredoxins (Trx’s) regulate redox signaling and are localized to various cellular compartments.
Speciﬁc redox-regulated pathways for adaptation of skeletal muscle to contractions are attenuated
during aging, but little is known about the roles of Trx’s in regulating these pathways. This study
investigated the susceptibility of Trx1 and Trx2 in skeletal muscle to oxidation and reduction in vitro
and the effects of aging and contractions on Trx1, Trx2, and thioredoxin reductase (TrxR) 1
and 2 contents and nuclear and cytosolic Trx1 and mitochondrial Trx2 redox potentials in vivo.
The proportions of cytosolic and nuclear Trx1 and mitochondrial Trx2 in the oxidized or reduced
forms were analyzed using redox Western blotting. In myotubes, the mean redox potentials were
nuclear Trx1, 251 mV; cytosolic Trx1, 242 mV; mitochondrial Trx2, 346 mV, data supporting the
occurrence of differing redox potentials between cell compartments. Exogenous treatment of myoblasts
and myotubes with hydrogen peroxide or dithiothreitol modiﬁed glutathione redox status and nuclear
and cytosolic Trx1, but mitochondrial Trx2 was unchanged. Tibialis anterior muscles from young and
old mice were exposed to isometric muscle contractions in vivo. Aging increased muscle contents of
Trx1, Trx2, and TrxR2, but neither aging nor endogenous ROS generated during contractions modiﬁed
Trx redox potentials, although oxidation of glutathione and other thiols occurred. We conclude that
glutathione redox couples in skeletal muscle are more susceptible to oxidation than Trx and that Trx
proteins are upregulated during aging, but do not appear to modulate redox-regulated adaptations to
contractions that fail during aging.
& 2012 Elsevier Inc. Open access under CC BY license.The ability of cells and tissues from old mammals to respond
to an oxidative stress by increasing the expression and activities
of antioxidant defense enzymes seems severely attenuated.
Previous data indicate that skeletal muscle from old rodents and
humans shows a number of changes in reactive oxygen species
(ROS) activities and actions in comparison to that from young
rodents and humans [1]. These include increased oxidative
damage to many biomolecules and a failure of ROS-stimulated
(redox-regulated) signaling systems [1]. In skeletal muscle of old
mice and humans there is increasing evidence that adaptations to
contractile activity are attenuated [2] and many of these adapta-
tions involve activation of redox-signaling pathways that mediate
changes in muscle gene expression [3]. A feasible explanation for
the inability of older muscle to respond to oxidative stress may be
failed redox signaling through inappropriate oxidation of key
regulatory molecules at speciﬁc subcellular sites.
Redox-dependent processes can inﬂuence the actions of many
proteins involved in regulation of vital cell functions such as
proliferation, differentiation, apoptosis, etc. [4,5]. Recent attention1
.
Y license.has focused on proteins that encompass thiol–disulﬁde regulation for
which the redox status depends on a redox-active site that has an
amino acid sequence containing one or two active thiols. The major
intracellular thiol–disulﬁde systems include reduced glutathione/
oxidized glutathione (GSH/GSSG) and the thioredoxin (Trx) systems.
These control diverse cellular events through discrete redox pathways
that inﬂuence redox signaling [6], are responsive to oxidative stress,
and help maintain intracellular redox homeostasis [4]. Trx’s are
a class of small multifunctional proteins that are present in all
prokaryotic and eukaryotic organisms and are characterized by the
invariant redox active-site sequence (Trp-Cys-Gly-Pro-Cys-Lys) [5].
The oxidized (inactive) form of Trx (TrxS2) has two cysteines at its
active site forming a disulﬁde bond that is reduced by thioredoxin
reductases (TrxR’s) in the cytosol (TrxR1) and mitochondria (TrxR2)
and NADPH to a dithiol (Trx(SH)2), which can then act as a general
protein disulﬁde reductase [5,7].
The Trx system is present in various cellular compartments; the
Trx1 isoform is found in the nucleus and cytosol. Distinct pools are
evident, as Trx1 can be imported into the nucleus from the
cytoplasm during various forms of oxidative stress [8,9]. Trx2 is
localized in mitochondria and is encoded by a nuclear gene and
localized to the mitochondrial matrix by a mitochondrial leader
sequence [10]. Trx2 is expressed ubiquitously and found at high
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brain, and liver, where it regulates the mitochondrial redox state
and may play an important role in cell proliferation [10–12].
Homozygous knockout of either isoform of Trx in mice is embry-
onically lethal [13,14] and Trx molecules are conserved throughout
evolution [15]. Trx1 and Trx2 interact with cysteine residues in
many proteins and have been implicated in cellular processes
including protein structure/folding, reductive and metabolic
enzymes, energy utilization, transcription factors, and immune
modulation [16]. Trx’s have also been implicated in aging, and
overexpression of either Trx1 or Trx2 has been shown to inﬂuence
life span in experimental models [17,18].
Understanding the redox modiﬁcations to proteins within
various cellular compartments such as cytosol, mitochondria, and
nuclei is of importance because cell signaling events can occur in
discrete compartments and antioxidant systems are not distribu-
ted uniformly throughout the cell. The development of models to
understand the redox potentials in various cell compartments and
how they are modiﬁed under physiological and pathophysiological
conditions could help facilitate the development of novel targeted
therapeutic interventions.
Thioredoxins seem to be key intracellular regulators of redox
signaling and the purpose of this study was to determine the
susceptibility of thioredoxins to reduction or oxidation by a physio-
logically relevant oxidant in various cellular compartments of a
well-characterized muscle cell line in culture in comparison with
the glutathione system. Additionally, anterior tibialis (AT) muscles
from young and old mice were exposed to an isometric muscle
contraction protocol to follow the relative changes in the redox
status of Trx1 and Trx2 in various cellular compartments in
comparison with their glutathione redox status. We reasoned that
an increased knowledge of the relative susceptibility to oxidation/
reduction of Trx1, Trx2, and GSH in various cell compartments
would facilitate a greater understanding of the changes seen in
muscle in response to physiological stress (contractions) or aging
in vivo. To undertake this, a cell fractionation method for C2C12
myoblasts and myotubes and skeletal muscle tissue from young and
old mice was initially developed and fractions were used
to analyze the redox status of Trx1 (in nuclear and cytosolic
fractions) and Trx2 from the same cells or tissue fraction using
redox Western blotting. These cell and tissue samples were also
analyzed for the protein content of Trx1, Trx2, TrxR1, and TrxR2;
total protein thiol content; and glutathione and oxidized glutathione
content. Data indicate that in skeletal muscle, exogenous ROS
modulators modiﬁed the redox status of the Trx1 system in nuclei
and cytosol; in vivo aging inﬂuenced the muscle content of Trx1,
Trx2, and TrxR2; but neither aging per se nor the physiological
generation of endogenous ROS by isometric contractions modiﬁed
the redox potential of the Trx proteins, although under both of these
conditions changes in glutathione and other thiols were seen.Material and methods
Mice and isometric muscle contraction protocol
Experiments were performed in accordance with UK Home
Ofﬁce guidelines under the UK Animals (Scientiﬁc Procedures)
Act 1986 and received ethical approval from the University of
Liverpool Animal Welfare Committee. A total of 30 male C57Bl6
mice were used in this study, 15 young (mean age: 6 months old)
and 15 old (mean age: 28 months old). Animals were maintained in
a temperature-controlled environment fed on a standard laboratory
chow diet ad libitum and subjected to a 12-h light–dark cycle.
Mice were anesthetized with ketamine hydrochloride (66 mg/kg
body wt) and medatomidine hydrochloride (0.55 mg/kg body wt)by intraperitoneal injection, and anesthesia was maintained with
additional ketamine (30 mg/kg body wt) as required. Each age
cohort was split into three equal groups: (i) control mice, which
did not receive the contraction protocol (unstimulated); (ii) mice
that received the contraction protocol and were sacriﬁced immedi-
ately at the end of the contractions; and (iii) mice that received the
contraction protocol and remained at rest for 15 min before sacri-
ﬁce. For the mice in groups ii and iii, both hindlimbs were subjected
to a 15-min period of electrical stimulation via surface electrodes
to generate isometric contractions of the hindlimb muscles. The
stimulation protocol used was a square wave pulse of 0.2 ms
duration at 60 V and a frequency of 100 Hz contracted every 4 s
and repeated 180 times. Mice were sacriﬁced by administration of
an overdose of anesthetic at the times described above and both AT
muscles were rapidly removed; half of one muscle was snap-frozen
in liquid nitrogen for use in analyses of Trx1, Trx2, TrxR1, TrxR2,
glutathione, and total protein thiol contents, and the remaining AT
tissue was processed immediately to obtain subcellular fractions for
redox Western blotting of Trx1 and Trx2.
Cell culture and treatments
The C2C12 mouse skeletal myoblast line was obtained from the
American Type Culture Collection (CRL-1772). C2C12 myoblasts were
maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM; Sigma
Aldrich, Poole, UK) supplemented with 1% L-glutamine (Lonza,
Cologne, Germany), 10% fetal bovine serum (FBS; Biosera, Sussex,
UK), and 1% penicillin and streptomycin (Sigma) under an atmo-
sphere of 5% CO2 in humidiﬁed air at 37 1C. To induce myogenic
differentiation, the growth medium was changed to differentiation
medium (DMEM supplemented with 2% horse serum and 1% anti-
biotics and L-glutamine) after myoblasts had reached 90% conﬂuence,
and the cells were allowed to mature to myotubes for 7 days.
Proliferating myoblasts and differentiated myotubes were
untreated, treated with hydrogen peroxide (H2O2; 300–500 mM),
or treated with 5 mM dithiothreitol (DTT); the treatments
were applied for 30 min at 37 1C in a tissue culture incubator.
Cells were then immediately harvested for cell fractionation and
biochemical analyses.
Subcellular fractionation
Cells and freshly harvested AT tissue were homogenized
in the presence of STM buffer (250 mM sucrose, 50 mM Tris,
5 mM MgCl2) with protease inhibitors (Sigma–Aldrich). For redox
Western blots, 50 mM iodoacetic acid (IAA) was added to the lysis
buffer and the pH was adjusted to pH 7.4 using 10 M NaOH
(in preliminary experiments, this step was found to prevent
artifactual oxidation of the Trx1 redox couple in the nuclear and
cytosolic extracts). The suspensions were incubated on ice for
5 min and then centrifuged at 12,000 g for 5 min at 4 1C; the
pellet (nuclear fraction) was immediately lysed in G-lysis buffer
(6 M guanidine–HCl, 50 mM Tris–HCl, pH 8.3, 3 mM EDTA, 0.5%
Triton X-100, 50 mM IAA; Sigma Aldrich). Proteins in the super-
natant (cytosolic fraction) were precipitated in cold 100% acetone
at 20 1C for 30 min followed by centrifugation at 12,000 g, and
the protein pellet was resuspended in G-lysis buffer.
Western blotting
The quality of the cell fractionation was determined for the
nuclear and cytosolic fractions (15–30 mg/fraction) by examining
marker proteins: histone H3 (nuclei) and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH; cytosol) using monoclonal
antibodies for histone H3 (Cell Signaling, Hertfordshire, UK,
1:2000) and GAPDH (Abcam, Cambridge, UK, 1:5000). Whole
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analyzed for the content of Trx1, Trx2, TrxR1, and TrxR2 using
polyclonal anti-rabbit Trx1, Trx2, and TrxR1 and anti-goat TrxR2
(Santa Cruz Biotechnology, Santa Cruz, CA, USA, 1:500). Protein
samples were separated by SDS/10–14% PAGE and transferred
onto a polyvinylidene diﬂuoride membrane (Sigma). Protein was
visualized after applying speciﬁc secondary horseradish perox-
idase (HRP)-conjugated antibodies and exposure to a Supersignal
West Dura substrate (Pierce-Thermo, Northumberland, UK).
Analysis of the viability of C2C12 cells
Myoblasts and myotubes were tested for their sensitivity to
hydrogen peroxide treatment. Cells (3103 per well) were seeded
in 96-well plates and grown overnight in a tissue culture incubator
in DMEM containing 10% FBS. Myoblasts were washed twice with
phosphate-buffered saline (PBS) and treated with H2O2 (300 mM)
for 30 min. C2C12 myotubes were allowed to differentiate for
7 days and then treated with 500 mM H2O2. Cell viability and
growth were determined using a Cell Titer 96 AQueous One Solution
Cell Proliferation Assay Kit (Promega, Milan, Italy).
For analysis of apoptotic markers, 20 mg of protein from each
cell extract was separated by SDS/PAGE. The following antibodies
were used: anti-rabbit caspase-9 and anti-rabbit Bax (Santa Cruz
Biotechnology, 1:1000) and anti-rabbit caspase-3 and anti-rabbit
Bcl-2 (Cell Signaling, Milan, Italy, 1:1000).
Redox western blotting
To allow separation of oxidized and reduced forms of Trx1
(i.e., the Trx1 redox state) homogenates were treated with IAA to
stabilize the redox state by binding to reduced Trx1 and preventing
further formation of oxidized Trx1. Reduced Trx1 bound to thiol-
reactive IAA has a different electrophoretic mobility compared with
oxidized Trx1 [19]. Brieﬂy, after 30 min at 37 1C, excess IAA was
removed using a protein desalting spin column (Pierce), and the
concentration of protein in the eluate was determined by BCA protein
assay (Sigma–Aldrich). Equivalent amounts of protein were loaded
from each cell fraction (50–150 mg) and the reduced and oxidized
Trx1were separated by native PAGE. The proteins were electroblotted
onto a nitrocellulose membrane and probed with anti-Trx1 antibody
(1:2000; Abcam) followed by an HRP-conjugated secondary antibody
(Cell Signaling). Bands corresponding to Trx1 were visualized using
ChemiDoc XRS (Bio-Rad, Hertfordshire, UK). Bands were quantiﬁed
using ImageJ software (W.S. Rasband, ImageJ, U.S. National Institutes
of Health, USA). The relative contents of oxidized and reduced Trx1
were entered into the Nernst equation to calculate Eh (redox
potential) values with E00 (midpoint potential)¼240mV at pH
7.0 at 25 1C [18].
Determination of the proportions of Trx2 in the reduced and
oxidized forms (i.e., Trx2 redox state) was undertaken using the
method of Go and Jones [20]. Cells were scraped into ice-cold PBS
and precipitated on ice with 10% trichloroacetic acid (TCA; Fisher
Scientiﬁc) for 30 min. AT tissue was minced with scissors and
homogenized with an electric Potter S homogenizer (Sartorius,
Surrey, UK) in PBS and then precipitated in 10% TCA for 30 min on
ice. Samples were centrifuged at 12,000 g for 10 min, resuspended
in 100% acetone, and incubated for 30 min on ice. After centrifu-
gation at 12,000 g for 10 min, acetone was removed, and protein
pellets were dissolved in lysis/derivatization buffer (20 mM Tris–HCl,
pH 8, 15mM 4-acetoamido-40-maleimidylstilbene-2,20-disulfonic
acid; Molecular Probes, Paisley, UK) and incubated at room tempera-
ture (22 1C) in the dark for 3 h. The reduced and oxidized Trx2 were
separated on an SDS/15% polyacrylamide gel (Geneﬂow, Staffordshire,
UK) in the presence of nonreducing loading buffer. Immunoblotting
was performed as described above, but utilized an anti-Trx2 (1:1000;Abcam) primary antibody followed by an HRP-conjugated secondary
antibody. The relative contents of oxidized and reduced Trx2 were
entered into the Nernst equation to calculate Eh values at 25 1C with
E00¼330mV at pH 7.6 (mitochondrial pH).
Preparation of samples for analysis of glutathione and total protein
thiol content
An aliquot of each tissue or cell sample was mixed with
1% (w/v) sulfosalicylic acid (Sigma–Aldrich). The samples were
then homogenized and centrifuged at 14,000g for 10 min at 4 1C,
supernatants were used for the analysis of glutathione (total and
oxidized forms), and the precipitated protein pellet was used for
the analysis of total protein and thiol content. The protein content
of samples was determined by the Bradford method.
Glutathione and total protein thiol analyses
The total protein thiol content was analyzed by the method
described by Di Monte et al. [21] adapted for use on a 96-well plate
reader. The automated glutathione recycling method [22] adapted for
a 96-well plate reader (Benchmark; Bio-Rad) was used to analyze the
total glutathione content of samples. The oxidized glutathione con-
tent was analyzed using the same method as described for total
glutathione utilizing 2-vinylpyridine [23] to prevent GSH oxidation
during sample preparation. The redox states (Eh) of the GSH/GSSG
pools were calculated using the Nernst equation [24]. The standard
midpoint potential E0 for the GSH/GSSG couple was 240mV at pH
7.0 [25].
Statistical analysis
Data are presented as means7SE for each experiment; for tissue
and cells n represents the number of mice used and different day
replicates, respectively. Data were evaluated for statistical signiﬁcance
using SPSS (version 17) using one-way ANOVA or Student’s t test as
appropriate. Po0.05 was considered signiﬁcant.Results
Efﬁciency of cell and tissue fractionation
Analyses of the marker proteins showed that relatively pure
separation of the nuclear and cytosolic fractions was achieved for
myoblasts, myotubes, and AT muscles (see Supplementary Fig. S1)
using the method described.
Analysis of the thioredoxin system in proliferating and differentiated
C2C12 cells
Fig. 1 shows the relative contents of Trx1, Trx2, TrxR1, and
TrxR2 obtained by Western analyses of untreated myoblasts and
myotubes, together with the lack of effect of short-term exposure
of myoblasts and myotubes to H2O2. Preliminary data indicated
that the concentrations of H2O2 utilized had no effect on the
viability nor did they induce markers of apoptosis in myoblasts or
myotubes (see Supplementary Fig, S2). The contents of TrxR1 and
TrxR2 in myoblasts were signiﬁcantly increased compared with
differentiated cells (myoblasts vs myotubes: TrxR1, 0.8570.13 vs
0.2970.09, P¼0.03; TrxR2, 0.6870.05 vs 0.2370.08, P¼0.008).
Treatment of myoblasts or myotubes with H2O2 did not result in
any changes in the content of Trx1, Trx2, TrxR1, or TrxR2 over the
time course of the study.
Fig. 1. Western blot analysis of the protein contents of Trx1, Trx2, TrxR1, and TrxR2 in C2C12 myoblasts and myotubes with and without exposure to H2O2. (A) Example
Western blots from myoblasts. (B) Example Western blots from myotubes. (C) Quantiﬁcation of the densitometry data from Western blots showing the effect of H2O2 (þ)
on Trx1, Trx2, TrxR1, and TrxR2. Values are presented as means7SE. *Po0.05 cf. myoblasts, **Po0.01 cf. myoblasts.
Fig. 2. Analysis of the redox status of Trx1 in nuclear and cytoplasmic fractions and mitochondrial Trx2 in C2C12 myoblasts. (A) Light microscopy image of C2C12
myoblast cells (bar, 200 mm). (B) Example redox blots showing the redox status of Trx1 and Trx2 in untreated cells and after DTT (5 mM) or H2O2 (300 mM) treatment.
Histograms showing changes in Eh values in (C) nuclear Trx1, (D) cytoplasmic Trx1, and (E) mitochondrial Trx2. The proportions of Trx1 and Trx2 in the reduced and
oxidized forms were quantiﬁed by densitometry and values were entered into the Nernst equation (see Material and methods) to calculate redox potentials. Results are
presented from at least three separate experiments. *Po0.05 compared with control.
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and differentiated C2C12 cells
Proliferating myoblasts
The effect of treatment of C2C12 myoblasts with DTT or H2O2 on
the redox status of nuclear and cytosolic Trx1 and mitochondrial Trx2
is shown in Fig. 2. The Trx1 redox blot shows two prominent
immunoreactive bands in which the dominant band was fully
carboxymethylated (i.e., reduced), with a less prominent band that
corresponded to a partially carboxymethylated (i.e., oxidized) state.
The steady-state redox potential (Eh) was calculated from densito-
metry of the two Trx bands. In untreated control cells, Trx1 was pre-
dominantly in the reduced state in both the cytosolic and the nuclear
fractions and the Trx1 redox potential in myoblasts was calculated
as approximately 250 mV for both subcellular compart-
ments (Figs. 2C and 2D). After exposure to H2O2, the myoblast
Trx1 redox potential was signiﬁcantly more reduced in both
compartments than before treatment (control vs H2O2: nuclei,
24970.6 mV vs 25870.7 mV; cytoplasm, 248.770.3 mV
vs 255.371.4 mV; all Po0.05). Treatment with the reducing
agent DTT caused a signiﬁcant reduction of both Trx1 compart-
ments compared with untreated control myoblasts (Fig. 2C,
DTT¼25571.6 mV; Fig. 2D, DTT¼28473.4 mV; Po0.05
vs control).
Trx2 exclusively localized to mitochondria, and two predominant
forms of Trx2 were found in myoblasts representing the reduced and
oxidized forms of the protein (Fig. 2B). The steady-state redox
potential was calculated from densitometry of the two Trx2 bands.
The redox potential of Trx2 in control untreated cells was calculated
to be approximately 346mV and this did not change signiﬁcantly
after treatment of cells with DTT or H2O2 (Fig. 2E).
Differentiated myotubes
The effect of treatment of differentiated myotubes with DTT
or H2O2 on the redox status of nuclear and cytosolic Trx1 andFig. 3. Analysis of the redox status of Trx1 in nuclear and cytoplasmic fractions and
myotubes (bar, 200 mm). (B) Example redox blots showing the redox status of Trx1 an
Histograms showing changes in Eh values in (C) nuclear Trx1, (D) cytoplasmic Trx1,
experiments. *Po0.05 compared with control.mitochondrial Trx2 is shown in Fig. 3. The Trx1 redox blot again
showed two prominent immunoreactive bands that corresponded to
the oxidized and reduced forms. In untreated myotubes, Trx1 was
predominantly in the reduced state in both the cytosolic and the
nuclear fractions and the Trx1 redox potential was calculated as
approximately 250mV for both subcellular compartments (Figs. 3C
and 3D). After exposure to H2O2, myotube Trx1 became more
oxidized in both the nuclei and the cytosol (control vs H2O2: nuclei,
251.170.4 mV vs 247.770.5 mV; cytosol, 242.271.7 mV vs
235.170.5 mV; Po0.05). Treatment with the reducing agent DTT
caused a signiﬁcant reduction of both Trx1 compartments compared
with untreated control myotubes (Fig., 3C, DTT¼255.470.5 mV;
Fig. 3D, DTT¼28471.4 mV; Po0.05 vs control).
There was no change in mitochondrial Trx2 redox status in
myotubes after either treatment (Fig. 3E); the redox potential of
Trx2 in myotubes was approximately 346 mV. Although no
differences were found between the nuclear redox potentials of
Trx1 or of mitochondrial Trx2 comparing untreated myoblasts to
myotubes, the cytosolic redox potential of Trx1 was signiﬁcantly
more oxidized in untreated myoblasts than found in untreated
myotubes (P¼0.02).
The sensitivity of glutathione to oxidation/reduction in proliferating
and differentiated C2C12 cells
Proliferating myoblasts
Total cellular protein thiol, GSH, and GSSG contents and the
cellular glutathione redox potential were measured in cells
treated in the same manner as for the Trx1 and Trx2 studies.
Myoblast total protein thiol content was unchanged after treat-
ment with DTT or H2O2 (Fig. 4A), the intracellular content of GSH
decreased signiﬁcantly with H2O2 treatment (Fig. 4B), but was
unchanged by DTT treatment, whereas the myoblast content of
GSSG was unchanged by either treatment as was the glutathione
redox potential (Figs. 4C and 4D).mitochondrial Trx2 in C2C12 myotubes. (A) Light microscopy image of C2C12
d Trx2 in untreated myotubes and after DTT (5 mM) or H2O2 (500 mM) treatment.
and (E) mitochondrial Trx2. Results are presented from at least three separate
Fig. 4. C2C12 myoblasts were untreated or exposed to either 5 mM DTT or 300 mM H2O2 for 30 min, and the (A) total thiol content, (B) total GSH, (C) GSSG, and
(D) glutathione redox potential were determined. Results are presented as means7SE (n¼3). *Po0.05 compared with control.
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Myotube total protein thiol content was unchanged after
treatment with DTT or H2O2 (Fig., 5A), the intracellular content of
GSH decreased signiﬁcantly with H2O2 treatment (Fig., 5B), but was
unchanged by DTT treatment. The myotube GSSG content was
unchanged by either treatment. There was a signiﬁcant oxidation
of the glutathione redox potential in response to H2O2 treatment
(Po0.009) compared with untreated myotubes (Fig. 5D).
The content of GSH was signiﬁcantly higher in myoblasts than
in myotubes irrespective of treatment (myoblasts vs myotubes
nmol/mg protein: control, 6.370.18 vs 2.370.32, Po0.05; DTT,
7.671.3 vs 2.370.17, Po0.05; H2O2, 3.770.5 vs 1.370.1,
Po0.05; Fig. 4B versus 5B). The myoblast GSSG content was also
up to fourfold greater than found in equivalently treated myo-
tubes (Figs. 4C and 5C) (myoblasts vs myotubes nmol/mg protein:
control, 0.1370.02. 0.0370.01, Po0.05; DTT, 0.2270.02 vs
0.0270.01, Po0.05; H2O2, 0.2170.12 vs 0.0470.01, P40.05).
No differences in GSH redox potential were found comparing
myoblast to myotubes exposed to the same treatment.
Trx1, Trx2, TrxR1, and TrxR2 content and subcellular thioredoxin
pools in AT muscles from mice subjected to an isometric muscle
contraction protocol
Muscles from old mice showed a signiﬁcant increase in the
protein contents of Trx1, Trx2, and TrxR2 compared with muscles
from young mice (Fig. 6). Redox blotting of Trx1 and Trx2 showedthat the muscle contraction protocol in vivo induced no signiﬁ-
cant changes in Trx1 or Trx2 oxidation status (Fig. 7), neither
were the redox potentials of Trx1 and Trx2 inﬂuenced by the age
of the mice. The nuclear and cytosolic Trx1 redox potential was
maintained between 230 and 234 mV, whereas the mito-
chondrial Trx2 redox potential was consistently more reduced
with values of approximately 310 mV in the resting state.
Total protein thiol, glutathione, and oxidized glutathione contents
and cellular glutathione redox potential in AT muscles from mice
subjected to an isometric muscle contraction protocol
The total protein thiol content of AT muscles was not altered
by the age of the mice, but was signiﬁcantly decreased in samples
obtained immediately after contractions and at 15 min post-
contractile activity in muscles from young mice (Fig. 8A). Muscles
from old mice showed the same pattern of changes, but data did
not reach statistical signiﬁcance. The glutathione content of AT
muscles from old mice was unresponsive to treatment and was
signiﬁcantly lower than that in muscles from young mice (Fig. 8B;
young, 1.6970.1 nmol/mg protein; old, 0.9470.12 nmol/mg
protein, Po0.05). The contraction protocol induced a reduction
in the glutathione content of the AT muscle of young mice, which
was seen both immediately after contraction and 15 min post-
contractile activity (Fig. 8B; control, 1.6970.1 nmol/mg protein;
stim, 1.3570.1; after 15 min rec, 1.4570.04), compared with
precontraction values. The GSSG contents were not different
Fig. 5. C2C12 myotubes were untreated or exposed to either 5 mM DTT or 500 mM H2O2 for 30 min, and the (A) total thiol content, (B) total GSH, (C) GSSG, and
(D) glutathione redox potential were determined. Results are presented as means7SE (n¼3). *Po0.05 compared with control and DTT-treated.
Fig. 6. Western blot analysis of the protein content of Trx1, Trx2, TrxR1, and TrxR2
in AT muscles from young and old mice. (A) Example Western blots for Trx1, Trx2,
TrxR1, and TrxR2. (B) Quantiﬁcation of the densitometry data from Western blots.
Values are presented as means7SE. *Po0.05 cf. values for young mice, **Po0.01
cf. values for young mice.
I. Dimauro et al. / Free Radical Biology and Medicine 53 (2012) 2017–2027 2023between the AT muscles from young and old mice and no effect of
the contraction protocol on GSSG content was seen in either age
group (Fig. 8C). The glutathione redox potential of muscles did not
differ signiﬁcantly between young and old mice although there
was a trend toward a more oxidized redox potential in muscles
from old mice, irrespective of treatment (Fig. 8D).Discussion
Protein oxidation with the formation of carbonyl groups and loss
of free thiol groups has generally been thought to be deleterious to
cells with, for example, enzyme function affected by oxidation of
essential thiol groups in active sites [26], but there is growing interest
in the roles of reversible oxidation of cysteine residues as a means of
redox regulation of normal biological processes. The transient oxida-
tion of thiol groups within speciﬁc proteins is the basis of redox
signaling in cells and seems to be part of the processes by which cells
respond to oxidants. GSH and Trx systems are key regulators of
redox-sensitive pathways and also contribute to the antioxidant
defenses of cells to protect cells from oxidative stress [27,28].
It has been shown that the redox state of Trx in speciﬁc cell
compartments is modulated by a variety of intra- and extracel-
lular stresses, including oxidative stress, caloric restriction, and
UV, in cell lines such as human colonic epithelial cells (HT29)
[29], human monocytic leukemia cells (THP1) [8,30], human
keratinocytes [31], and bovine aorta endothelial cells [32].
Fig. 7. Example redox blots of nuclear and cytoplasmic Trx1 and mitochondrial Trx2 from AT muscles of young and old mice at rest (control), immediately after a 15-min
isometric muscle contraction (Stim), or after a 15-min recovery period (Rec). Histograms showing changes in Eh values of (B) nuclear Trx1, (C) cytoplasmic Trx1, and
(D) mitochondrial Trx2. The proportion of Trx1 and Trx2 in the reduced and oxidized forms was quantiﬁed by densitometry and values were entered into the Nernst
equation (see Material and methods) to calculate redox potentials (n¼5 animals for each group). Cells exposed to DTT and H2O2 shown in (A) were used as positive controls.
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utilized H2O2 and DTT to examine the effects of exogenous
stresses on the redox potential of cytosolic, nuclear, and mito-
chondrial Trx systems using the C2C12 skeletal muscle cell line.
We reasoned that understanding the susceptibility of Trx1, Trx2,
and GSH to oxidation and reduction in a relevant muscle cell line
would help the interpretation of changes in skeletal muscle
in vivo because no previous data are available for this tissue.
During contractile activity of skeletal muscle the tissue generated
speciﬁc ROS and muscle cells released ROS including H2O2 [2]. The
magnitude of the contraction-induced increase in H2O2 that occurs
has not been well deﬁned, but our previous calculations [33]
indicate that the mean rise in intracellular H2O2 content may be
less than 1 mM. Preliminary experiments undertaken for this study
identiﬁed a concentration of H2O2 that modiﬁed the redox poten-
tial of Trx1 without any signiﬁcant effect on cell death (see
Supplementary Fig. S2). These studies (not reported in detail)
identiﬁed various concentrations of H2O2 for myoblasts (300 mM)
and myotubes (500 mM). Previous data also suggest that these
concentrations of extracellular H2O2 will lead to a transient
increase in intracellular H2O2 of 30–50 mM [33]. Although this is
much higher than the mean rise in intracellular H2O2 calculated to
occur during contractile activity, there is no current information on
local concentrations of H2O2 that occur adjacent to the sites of
generation although these must inevitably be considerably higher.
Several previous studies have investigated the susceptibility of
myoblasts and myotubes to oxidation induced by H2O2 but there is
still debate about their relative susceptibilities [34,35].
Halvey et al. [31] and Hansen et al. [36] have reported that the
Trx systems in various cell compartments are not in redox
equilibrium and that typically mitochondria are most reduced,
nuclei are intermediate, and the cytoplasm is most oxidized.
This pattern was observed in this study in proliferating and
differentiated C2C12 cells and in intact AT muscles. In untreated
cells, the nuclear, cytosolic, and mitochondrial pools of Trx’s were
predominantly in the fully reduced form; nuclear Trx1 was 70%reduced, cytosolic Trx1 was 60% reduced, and mitochondrial
Trx2 was 80% reduced. The calculated redox potentials of
the various pools of dithiols were nuclear Trx1 approximately
250 mV, cytosolic Trx1 approximately 240 mV, and Trx2
approximately 345 mV.
Rohrbach et al. [37] reported a modiﬁcation of components of
the thioredoxin system after oxidative stress, but application of
H2O2 to C2C12 myoblasts over the time course of this study did not
modify the content of Trx1, Trx2, TrxR1, or TrxR2, but induced an
unexpected decrease in the redox potential of Trx1 (i.e., this
became more reduced). The mechanisms underlying these ﬁndings
are unclear, but our data do not support the possibility that this
was due to modiﬁcation of TrxR content. A modiﬁcation of cell
NADPH content might explain the changes observed, but unfortu-
nately it was not possible to study this aspect as part of this study.
Similarly, treatment with H2O2 did not change the protein content
of the components of the thioredoxin system in differentiated C2C12
myotubes, although we observed that the basal levels of TrxR1 and
TrxR2 were signiﬁcantly lower than found in myoblasts as was
reported previously [38]. Results from differentiated myotubes also
provided evidence that oxidation of individual subcellular compart-
ments can occur in the absence of a generalized cellular oxidation.
C2C12 myotubes showed oxidation of cytosolic and nuclear Trx1
without affecting the redox state of Trx2. Trx1 and Trx2 belong to the
same protein family and both contain conserved active centers, which
show similar in vitro oxidation by ROS and function as critical
components of the local antioxidant network in speciﬁc subcellular
compartments. Several studies have demonstrated they have differ-
ent sensitivities to an external oxidative stress [10,30,31]. These data
suggest that Trx2 was less prone to oxidation in vitro and that the
Trx2 redox state was regulated independent of that of the Trx1 pool.
Trx1 was found to respond to exogenous H2O2, whereas mitochon-
drial Trx2 was unaffected. The physical structure of muscle cells may
play a role in inﬂuencing access to subcellular organelles, as may the
relative differences in the volumes of the mitochondrial reticulum
within myotubes and myoblasts. To further characterize the response
Fig. 8. Effects of the isometric muscle contraction protocol on (A) total thiol content, (B) total GSH, (C) GSSG, and (D) glutathione redox potential of AT muscle from groups
of young and old mice (n¼5 animals for each group). *Po0.05 compared to mice in the precontractions young group. yPo0.05 compared with values from young mice in
the same pre- or postcontraction group.
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with DTT, a commonly used agent to reduce disulﬁde bonds in
proteins [39]. The data obtained indicate that both nuclear and
cytoplasmic Trx1 were more responsive to DTT treatment than
mitochondrial Trx2 in a manner analogous to the pattern seen after
treatment with H2O2.
In general, for both myoblasts and myotubes, the Trx1 redox
potentials responded similarly to the treatments, with Trx2 in
both cell types being unresponsive to treatment and successfully
maintaining the reduced environment that is necessary for
normal electron transport chain activity.
Analysis of the GSH content of cells showed that the concentration
was higher in proliferating C2C12 cells than in differentiated cells.
Previous studies have reported that GSH concentrations are highest
when cells are preparing for, or actively undergoing, cell division,
followed by a substantial decrease in the intracellular GSH concen-
tration in cells that are not dividing and expressing markers of
differentiation [40,41]. In this case the concentrations of GSH may
relate to the cell’s metabolic capacity to generate ROS through cellular
processes, because proliferating myoblasts are more metabolically
active than differentiated myotubes. After H2O2 treatment, both
myoblasts and myotubes showed signiﬁcant decreases in total GSH.
However, the GSH/GSSG redox potential became signiﬁcantly more
oxidized only inmyotubes. These data are in accord with the proposal
by Jones and Go [42] that GSH is more responsive to oxidative
signaling in differentiated cells than in proliferating cells.
We hypothesized that understanding the redox sensitivities of
subcellular compartments in skeletal muscle might be a poten-
tially powerful approach for identifying new pathways and
pharmacological tools to inﬂuence muscle function and targetantioxidant defenses particularly during aging. Trx’s in vivo are
exposed to diverse and dynamic microenvironments and there
are no appropriate in vitro models to study these antioxidant
systems within skeletal muscles during aging. The data obtained
indicate that aging in skeletal muscle is associated with an
increase in the muscle content of Trx1, Trx2, and TrxR2, changes
that may reﬂect aging-related adaptations to maintain Trx func-
tion and cellular redox balance and prevent oxidative damage.
Overexpression of Trx1 or Trx2 has previously been shown to
inﬂuence life span in mice [17,18], supporting the key role played
by this protein in aspects of the aging process.
We report here the redox potentials of Trx and GSH in
subcellular compartments of the skeletal muscle system of old
and young mice in vivo. We also report the relative changes in the
redox status of Trx1 and Trx2 from different cellular compart-
ments in comparison with the glutathione redox status of AT
muscles of young and old mice exposed to an isometric muscle
contraction protocol previously shown to induce an increase in
intracellular ROS [43,44].
Current literature on the status of the Trx system during aging is
scant and this area has not been studied extensively [45,46]. These
results suggest that a tissue-speciﬁc modulation of Trx activity may
be related to the functional state of the organ under oxidative stress.
The current work has shown that the redox status of both Trx’s was
unchanged in muscle from old compared with young mice although
there was an increase in Trx1 and Trx2 content in muscle from old
mice. These data suggest that the increase in Trx1, Trx2, and TrxR2
proteins is a compensatory response to counteract increased oxida-
tive stress during the aging process [47]. Data also support the
possibility that the increase in ROS generated during the contraction
I. Dimauro et al. / Free Radical Biology and Medicine 53 (2012) 2017–20272026protocol must be relatively modest in young and old mice and
unlikely to present a major ‘‘oxidative stress’’ sufﬁcient to oxidize
the Trx’s (despite the protocol being sufﬁcient to cause changes in
total muscle protein thiols and glutathione levels).
Published data indicate that aging is associated with a decrease in
the extracellular GSH/GSSG redox potential [6], but estimates of
intracellular redox potentials from muscles of old organisms have
not been undertaken. In common with other studies [2,48,49], our
data from skeletal muscles of old and young mice indicate that the
oxidized glutathione content did not differ, but the total glutathione
content of quiescent muscles from old mice was signiﬁcantly lower
than that of young mice although the GSH redox potentials were not
signiﬁcantly different comparing either the control or the recovery
groups (P¼0.07). The total protein thiol content of muscles from old
mice was unchanged in the group compared with the young group
and showed no signiﬁcant response after contractions. Signiﬁcant
effects of contractile activity were seen only in the muscles of young
mice in which both the total protein thiol content and the glutathione
content decreased after contractions as previously reported [2].
Thus in proliferating and differentiated muscle cells and in
mouse muscle in vivo, glutathione and the total cell content of
protein thiols seem more prone to oxidation during physiolo-
gical stimuli than either Trx1 or Trx2. Unfortunately it is not
possible to measure subcellular compartments of GSH in a
manner similar to Trx1 and Trx2, but the data obtained
support the possibility that GSH is more sensitive to exogen-
ous and endogenous oxidants than Trx1 or Trx2. The cause of
the decrease in GSH that occurs in muscle from young mice in
response to contractions is unclear but has been previously
attributed to oxidation of GSH by endogenous ROS generated
during contractile activity and subsequent loss of the oxidized
GSSG from the muscle cell [50]. Recent data have implicated
the contraction-induced changes in cellular redox potentials
as a key mechanistic step in speciﬁc adaptive responses to
contractions that fail in aging [3], and the current GSH and
protein thiol data are fully compatible with this, but also fail
to implicate changes in Trx1 or Trx2 in the process.
In conclusion, these data provide the ﬁrst clear evidence that
skeletal muscle aging is associated with changes in the expression of
Trx and the GSH system but not with oxidation/reduction of
thioredoxin proteins and that the physiological stress of contractions
also predominantly inﬂuences muscle GSH rather than Trx1 or Trx2.
The development of methods to measure the redox status of speciﬁc
proteins in various organelles will allow more complete delineation
of the role of compartment-speciﬁc redox pathways and how they
are inﬂuenced by aging. Many age-related disorders are associated
with changes in redox states and redox regulation of protein thiols.
The development of models that establish the interconnections
between redox pathways and their responses during oxidative stress
will aid our understanding of the complex regulation of redox
processes under normal and pathological conditions.Acknowledgments
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